Literature DB >> 5103321

Hycanthone resistance: development in Schistosoma mansoni.

S H Rogers, E Bueding.   

Abstract

Following the administration of relatively high doses of the antischistosomal drug hycanthone to mice and hamsters infected with Schistosoma mansoni, a number of the worms survived. After a period of 6 to 12 months these parasites resumed production of viable eggs that gave rise to schistosomes that proved resistant to hycanthone and to two other related antischistosomal compounds. This drug resistance has remained stable for three subsequent generations of worms.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5103321     DOI: 10.1126/science.172.3987.1057

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  15 in total

1.  Inhibition of in vitro RNA synthesis by hycanthone, oxamniquine and praziquantel.

Authors:  L J Wong; G C Tsao; J I Bruce; S S Wong
Journal:  Experientia       Date:  1990-05-15

2.  Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C 9333-Go/CGP 4540).

Authors:  E Bueding; R Batzinger; G Petterson
Journal:  Experientia       Date:  1976-05-15

Review 3.  Intestinal parasites.

Authors:  R Knight; M G Schultz; D W Hoskins; P D Marsden
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

4.  Aspects of the effect of thioxanthone on Schistosoma mansoni in mice and in vitro.

Authors:  H G Lee
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

5.  Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy.

Authors:  Alexander B Taylor; Kenneth M Roberts; Xiaohang Cao; Nathaniel E Clark; Stephen P Holloway; Enrica Donati; Chiara M Polcaro; Livia Pica-Mattoccia; Reid S Tarpley; Stanton F McHardy; Donato Cioli; Philip T LoVerde; Paul F Fitzpatrick; P John Hart
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

Review 6.  The redox biology of schistosome parasites and applications for drug development.

Authors:  Hsin-Hung Huang; Coraline Rigouin; David L Williams
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Characterization of a programmed alteration in an 18S ribosomal gene that accompanies the experimental induction of drug resistance in Schistosoma mansoni.

Authors:  P J Brindley; S Heath; A P Waters; T F McCutchan; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites.

Authors:  Claudia L L Valentim; Donato Cioli; Frédéric D Chevalier; Xiaohang Cao; Alexander B Taylor; Stephen P Holloway; Livia Pica-Mattoccia; Alessandra Guidi; Annalisa Basso; Isheng J Tsai; Matthew Berriman; Claudia Carvalho-Queiroz; Marcio Almeida; Hector Aguilar; Doug E Frantz; P John Hart; Philip T LoVerde; Timothy J C Anderson
Journal:  Science       Date:  2013-11-21       Impact factor: 47.728

9.  New insights into the genetic diversity of Schistosoma mansoni and S. haematobiumin Yemen.

Authors:  Hany Sady; Hesham M Al-Mekhlafi; Bonnie L Webster; Romano Ngui; Wahib M Atroosh; Ahmed K Al-Delaimy; Nabil A Nasr; Kek Heng Chua; Yvonne A L Lim; Johari Surin
Journal:  Parasit Vectors       Date:  2015-10-20       Impact factor: 3.876

10.  Praziquantel treatment decreases Schistosoma mansoni genetic diversity in experimental infections.

Authors:  Regina Coeli; Elio H Baba; Neusa Araujo; Paulo M Z Coelho; Guilherme Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.